Podcasts
Listen to the latest hemonc news from international experts
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
The Post-EBMT VJSessions from VJHemOnc
The 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) was held virtually this year and showcased the latest advances in the field of transplantation and cellular therapies.
VJHemOnc is joined by Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, who chaired an insightful discussion on the main takeaways from the EBMT 2021 meeting, including trial updates in conditioning, novel approaches to managing graft-versus-host disease, the role of transplantation in rarer hematological malignancies and the latest news in immune effector cell therapies.
In this roundtable discussion, Prof. Chabannon is joined by Nico Gagelmann, MD, of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Zinaida Perić, MD, PhD, of the University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia and Eolia Brissot, MD, of Saint-Antoine Hospital, Paris, France.
Date: 7th April 2021
